Targeted disruption of Dkc1, the gene mutated in X-linked dyskeratosis congenita, causes embryonic lethality in mice

Oncogene

Volumn 21, Issue 50, 2002, Pages 7740-7744

  He, Jun ^a   Navarrete, Sandra ^a   Jasinski, Murek ^a   Vulliamy, Tom ^b   Dokal, Inderjeet ^b   Bessler, Monica ^a   Mason, Philip J ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Dkc1 deficient mice; Dyskeratosis congenita; Dyskerin; Telomerase

Indexed keywords

CRE RECOMBINASE; DYSKERIN; NUCLEAR PROTEIN; TELOMERASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MARROW DEPRESSION; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DELETION MUTANT; DYSKERATOSIS CONGENITA; EMBRYO; EMBRYO DEVELOPMENT; EMBRYO MORTALITY; ENZYME ACTIVITY; EXON; FEMALE; GENE DISRUPTION; GENE MUTATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA PROCESSING; X CHROMOSOME INACTIVATION; X CHROMOSOME LINKAGE;

ANIMALIA; MURINAE;

EID: 0037206947     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1205969     Document Type: Article

References (27)

1. Alter BP and Young NS. (1998). Hematology of infancy and childhood. Vol. 1. Nathan DG and Oski FA. (eds). Philadelphia: WB Sunders Company, pp 216-316.
2. Blasco MA, Lee HW, Hande MP, Samper E, Lansdorp PM, DePinho RA and Greider CW. (1997). Cell, 91, 25-34.
3. Cadwell C, Yoon HJ, Zebarjadian Y and Carbon J. (1997). Mol. Cell. Biol., 17, 6175-6183.
4. Giordano E, Peluso I, Senger S and Furia M. (1999). J. Cell. Biol., 144, 1123- 1233.
5. Harper MI, Fosten M and Monk M. (1982). J. Embryol. Exp. Morphol., 67, 127-135.
6. Heiss NS, Knight SW, Vulliamy TJ, Klauck SM, Wiemann S, Mason PJ, Poustka A and Dokal I. (1998). Nat. Genet., 19, 32-38.
7. Hemann MT and Greider CW. (2000). Nucleic Acids Res., 28, 4474-4478.
8. Keller P, Tremml G, Rosti V and Bessler M. (1999). Proc. Natl. Acad. Sci., 96, 7479-7483.
9. Knight SW, Heiss NS, Vulliamy TJ, Aalfs CM, McMahon C, Richmond P, Jones A, Hennekam RC, Poustka A, Mason PJ and Dokal I. (1999a). Br. J. Haematol., 107, 335-339.
10. Knight SW, Heiss NS, Vulliamy TJ, Greschner S, Stavrides G, Pai GS, Lestringant G, Varma N, Mason PJ, Dokal I and Poustka A. (1999b). Am. J. Hum. Genet., 65, 50-58.
11. Knight SW, Vulliamy TJ, Morgan B, Devriendt K, Mason PJ and Dokal I. (2001). Hum. Genet., 108, 299-303.
12. Lafontaine DL, Bousquet-Antonelli C, Henry Y, Caizergues-Ferrer M and Tolleryey D. (1998). Genes Dev., 12, 527-537.
13. Lakso M, Pichel JG, Gorman JR, Sauer B, Okamoto Y, Lee E, Alt FW and Westphal H. (1996). Proc, Natl, Acad. Sci. USA, 93, 5860-5865.
14. Liu Y, Snow BE, Hande MP, Yeung D, Erdmann NJ, Wakeham A, Itie A, Siderovski DP, Lansdorp PM, Robinson MO and Harrington L. (2000). Curr. Biol., 10, 1459-1462.
15. Mao X, Fujiwara Y and Orkin SH, (1999). Proc. Natl. Acad. Sci. USA, 96, 5037-5042.
16. Marciniak RA, Johnson FB and Guarente L. (2000). Trends Genet., 16, 193-195.
17. McDevitt MA, Fujiwara Y, Shivdasani RA and Orkin SH. (1997). Proc. Natl. Acad. Sci. USA, 94, 7976-7981.
18. Mitchell JR, Cheng J and Collins K. (1999a). Mol. Cell. Biol., 19, 567-576.
19. Mitchell JR, Wood E and Collins K. (1999b). Nature, 402, 551-555.
20. Prescott JC and Blackburn EH. (1999). Curr. Opin. Genet. Dev., 9, 368-373.
21. Razin A. (1998). EMBO J., 17, 4905-4908.
22. Spedaliere CJ, Hamilton CS and Mueller EG. (2000). Biochemistry, 39, 9459-9465.
23. Vulliamy T, Marrone A, Dokall I and Mason PJ. (2002). Lancet, 359, 2168-2170.
24. Vulliamy T, Marrone A, Goldman F, Dearlove A, Bessler M, Mason PJ and Dokal I. (2001a). Nature, 413, 432-435.
25. Vulliamy TJ, Knight SW, Heiss NS, Smith OP, Poustka A, Dokal I and Mason PJ. (1999). Blood, 94, 1254-1260.
26. Vulliamy TJ, Knight SW, Mason PJ and Dokal I. (2001b). Blood Cells Mol. Dis., 27, 353-357.
27. Zebarjadian Y, King T, Fournier MJ, Clarke L and Carbon J. (1999). Mol. Cell. Biol., 19, 7461-7472.